141 related articles for article (PubMed ID: 38145795)
21. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
[TBL] [Abstract][Full Text] [Related]
22. Electron microscopic DOPA reaction test for oculocutaneous albinism.
Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
[TBL] [Abstract][Full Text] [Related]
23. Ophthalmo-genetic analysis of Pakistani patients with nonsyndromic oculocutaneous albinism through whole exome sequencing.
Gul H; Ali MZ; Khan E; Zubair M; Badar M; Khan S; Shah AH; Khan MA
J Pak Med Assoc; 2017 May; 67(5):790-792. PubMed ID: 28507374
[TBL] [Abstract][Full Text] [Related]
24. [Genetics of oculocutaneous albinism].
Zühlke C; Stell A; Käsmann-Kellner B
Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
[TBL] [Abstract][Full Text] [Related]
25. Mutation spectrum of the TYR and SLC45A2 genes in patients with oculocutaneous albinism.
Ko JM; Yang JA; Jeong SY; Kim HJ
Mol Med Rep; 2012 Apr; 5(4):943-8. PubMed ID: 22294196
[TBL] [Abstract][Full Text] [Related]
26. Tyrosinase gene mutations in the Chinese Han population with OCA1.
Liu N; Kong XD; Shi HR; Wu QH; Jiang M
Genet Res (Camb); 2014 Nov; 96():e14. PubMed ID: 25577957
[TBL] [Abstract][Full Text] [Related]
27. DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics.
Simeonov DR; Wang X; Wang C; Sergeev Y; Dolinska M; Bower M; Fischer R; Winer D; Dubrovsky G; Balog JZ; Huizing M; Hart R; Zein WM; Gahl WA; Brooks BP; Adams DR
Hum Mutat; 2013 Jun; 34(6):827-35. PubMed ID: 23504663
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis and prenatal diagnosis of 20 Chinese families with oculocutaneous albinism.
Xu C; Xiang Y; Li H; Xu Y; Mao Y; Zhou L; Xu X; Tang S
J Clin Lab Anal; 2021 Feb; 35(2):e23647. PubMed ID: 33124154
[TBL] [Abstract][Full Text] [Related]
29. Haplotype-based analysis resolves missing heritability in oculocutaneous albinism type 1B.
Loftus SK; Gillis MF; Lundh L; Baxter LL; Wedel JC; Watkins-Chow DE; Donovan FX; ; Sergeev YV; Oetting WS; Pavan WJ; Adams DR
Am J Hum Genet; 2023 Jul; 110(7):1123-1137. PubMed ID: 37327787
[TBL] [Abstract][Full Text] [Related]
30. Mutation Analysis of 63 Northwest Chinese Probands with Oculocutaneous Albinism.
Chuan Z; Yan Y; Hao S; Zhang Q; Zhou B; Feng X; Wang X; Liu F; Zheng L; Cao Z; Ma X
Curr Eye Res; 2021 Jan; 46(1):140-143. PubMed ID: 32552135
[TBL] [Abstract][Full Text] [Related]
31. Mutational spectrum of the TYR and SLC45A2 genes in Pakistani families with oculocutaneous albinism, and potential founder effect of missense substitution (p.Arg77Gln) of tyrosinase.
Shah SA; Raheem N; Daud S; Mubeen J; Shaikh AA; Baloch AH; Nadeem A; Tayyab M; Babar ME; Ahmad J
Clin Exp Dermatol; 2015 Oct; 40(7):774-80. PubMed ID: 25703744
[TBL] [Abstract][Full Text] [Related]
32. Functional assessment of tyrosinase variants identified in individuals with albinism is essential for unequivocal determination of genotype-to-phenotype correlation.
Mondal M; Sengupta M; Ray K
Br J Dermatol; 2016 Dec; 175(6):1232-1242. PubMed ID: 27537549
[TBL] [Abstract][Full Text] [Related]
33. [Oculocutaneous and ocular albinism].
Kubasch AS; Meurer M
Hautarzt; 2017 Nov; 68(11):867-875. PubMed ID: 29018889
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of two novel noncoding tyrosinase (TYR) gene variants leading to oculocutaneous albinism type 1.
Li C; Chen Q; Wu J; Ren J; Zhang M; Wang H; Li J; Tang Y
J Biol Chem; 2022 May; 298(5):101922. PubMed ID: 35413289
[TBL] [Abstract][Full Text] [Related]
35. Mutations of the tyrosinase gene in three Korean patients with type I oculocutaneous albinism.
Park KC; Park SK; Lee YS; Youn SW; Park BS; Kim KH; Lee ST
Jpn J Hum Genet; 1996 Sep; 41(3):299-305. PubMed ID: 8996965
[TBL] [Abstract][Full Text] [Related]
36. A novel missense mutation of the TYR gene in a pedigree with oculocutaneous albinism type 1 from China.
Lin YY; Wei AH; Zhou ZY; Zhu W; He X; Lian S
Chin Med J (Engl); 2011 Oct; 124(20):3358-61. PubMed ID: 22088535
[TBL] [Abstract][Full Text] [Related]
37. Genetic Causes of Oculocutaneous Albinism in Pakistani Population.
Sajid Z; Yousaf S; Waryah YM; Mughal TA; Kausar T; Shahzad M; Rao AR; Abbasi AA; Shaikh RS; Waryah AM; Riazuddin S; Ahmed ZM
Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33800529
[TBL] [Abstract][Full Text] [Related]
38. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
[TBL] [Abstract][Full Text] [Related]
39. Ocular findings in patients with oculocutaneous albinism type ia with G47D tyrosinase gene mutation in Puerto Rico: a case report.
Rodríguez-Agramonte F; Izquierdo NJ; Cadilla C
Bol Asoc Med P R; 2013; 105(2):62-4. PubMed ID: 23882993
[TBL] [Abstract][Full Text] [Related]
40. Genotype-phenotype associations in Danish patients with ocular and oculocutaneous albinism.
Kessel L; Kjer B; Lei U; Duno M; Grønskov K
Ophthalmic Genet; 2021 Jun; 42(3):230-238. PubMed ID: 33612058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]